Provided by Tiger Fintech (Singapore) Pte. Ltd.

CRISPR Therapeutics AG

43.84
+0.39000.90%
Post-market: 44.020.1800+0.41%19:48 EST
Volume:1.19M
Turnover:51.76M
Market Cap:3.76B
PE:-10.10
High:44.35
Open:43.50
Low:42.35
Close:43.45
Loading ...

Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates

GlobeNewswire
·
6 hours ago

Shareholders in CRISPR Therapeutics (NASDAQ:CRSP) are in the red if they invested a year ago

Simply Wall St.
·
10 hours ago

AI Biotech Stocks Shined, With Ginkgo Up 8%, Recursion And Absci Up 4%, Crispr Up 3%

Tiger Newspress
·
Yesterday

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Yesterday

Top Executive Makes Bold Move with Major Stock Purchase!

TIPRANKS
·
01 Mar

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

Motley Fool
·
28 Feb

Intellia Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Company Progress

GlobeNewswire
·
27 Feb

AI Biotech Stocks Tumbled, with HIMS Plunging 17% and TEM Slumping 15%

Tiger Newspress
·
25 Feb

Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology

PR Newswire
·
24 Feb

Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March

GlobeNewswire
·
24 Feb

2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall Street

Motley Fool
·
24 Feb

CRISPR Therapeutics AG (CRSP): the Most Oversold Pharma Stock to Buy According to Analysts

Insider Monkey
·
24 Feb

Crispr Therapeutics Is Maintained at Buy by Citigroup

Dow Jones
·
19 Feb

CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?

Zacks
·
18 Feb

24H | Chinese ADRs and ETFs Extended Gains; YINN up 6%; XPeng, Alibaba up 5%; Li Auto up 4%; PDD Holdings up 2%; NIO up 1%

Tiger Newspress
·
18 Feb

Street Calls of the Week

Investing.com
·
16 Feb